Articles with public access mandates - Travis HollmannLearn more
Available somewhere: 82
Genetic basis for clinical response to CTLA-4 blockade in melanoma
A Snyder, V Makarov, T Merghoub, J Yuan, JM Zaretsky, A Desrichard, ...
New England Journal of Medicine 371 (23), 2189-2199, 2014
Mandates: US National Institutes of Health
Molecular determinants of response to anti–programmed cell death (PD)-1 and anti–programmed death-ligand 1 (PD-L1) blockade in patients with non–small-cell lung cancer profiled …
H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ...
Journal of clinical oncology 36 (7), 633-641, 2018
Mandates: US National Institutes of Health
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
CJ Ceol, Y Houvras, J Jane-Valbuena, S Bilodeau, DA Orlando, V Battisti, ...
Nature 471 (7339), 513-517, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learning
NF Greenwald, G Miller, E Moen, A Kong, A Kagel, T Dougherty, ...
Nature biotechnology 40 (4), 555-565, 2022
Mandates: Bill & Melinda Gates Foundation, US Department of Defense, US National …
The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution
O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ...
Cell 181 (2), 236-249, 2020
Mandates: Swiss National Science Foundation, US National Institutes of Health, Howard …
Adipocyte-derived lipids mediate melanoma progression via FATP proteins
M Zhang, JS Di Martino, RL Bowman, NR Campbell, SC Baksh, ...
Cancer discovery 8 (8), 1006-1025, 2018
Mandates: US National Institutes of Health
PRAME expression in melanocytic tumors
C Lezcano, AA Jungbluth, KS Nehal, TJ Hollmann, KJ Busam
The American journal of surgical pathology 42 (11), 1456-1465, 2018
Mandates: US National Institutes of Health
Emergence of a high-plasticity cell state during lung cancer evolution
ND Marjanovic, M Hofree, JE Chan, D Canner, K Wu, M Trakala, ...
Cancer cell 38 (2), 229-246. e13, 2020
Mandates: US National Science Foundation, US National Institutes of Health, Howard …
Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
T Wiesner, W Lee, AC Obenauf, L Ran, R Murali, QF Zhang, EWP Wong, ...
Nature 526 (7573), 453-457, 2015
Mandates: US National Institutes of Health
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
JM Chan, A Quintanal-Villalonga, VR Gao, Y Xie, V Allaj, O Chaudhary, ...
Cancer cell 39 (11), 1479-1496. e18, 2021
Mandates: US National Institutes of Health
The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
JM Taube, G Akturk, M Angelo, EL Engle, S Gnjatic, S Greenbaum, ...
Journal for immunotherapy of cancer 8 (1), 2020
Mandates: US National Institutes of Health
Metastasis and immune evasion from extracellular cGAMP hydrolysis
J Li, MA Duran, N Dhanota, WK Chatila, SE Bettigole, J Kwon, RK Sriram, ...
Cancer discovery 11 (5), 1212-1227, 2021
Mandates: US National Institutes of Health, UK Medical Research Council
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
LJ Padrón, DM Maurer, MH O’Hara, EM O’Reilly, RA Wolff, ZA Wainberg, ...
Nature medicine 28 (6), 1167-1177, 2022
Mandates: US National Institutes of Health
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
A Jiménez-Sánchez, P Cybulska, KLV Mager, S Koplev, O Cast, ...
Nature Genetics 52 (6), 582-593, 2020
Mandates: US Department of Defense, US National Institutes of Health, Cancer Research …
Microenvironment-derived factors driving metastatic plasticity in melanoma
IS Kim, S Heilmann, ER Kansler, Y Zhang, M Zimmer, K Ratnakumar, ...
Nature communications 8 (1), 14343, 2017
Mandates: US National Institutes of Health
Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L) 1 blockade in patients with non-small cell lung cancer
RS Vanguri, J Luo, AT Aukerman, JV Egger, CJ Fong, N Horvat, ...
Nature cancer 3 (10), 1151-1164, 2022
Mandates: US National Institutes of Health, Damon Runyon Cancer Research Foundation …
Novel high-grade endometrial stromal sarcoma: a morphologic mimicker of myxoid leiomyosarcoma
LN Hoang, A Aneja, N Conlon, DF Delair, S Middha, R Benayed, ...
The American journal of surgical pathology 41 (1), 12-24, 2017
Mandates: US National Institutes of Health
NF1 mutations are common in desmoplastic melanoma
T Wiesner, M Kiuru, SN Scott, M Arcila, AC Halpern, T Hollmann, ...
The American journal of surgical pathology 39 (10), 1357-1362, 2015
Mandates: US National Institutes of Health
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors
F Pareja, AH Brandes, T Basili, P Selenica, FC Geyer, D Fan, ...
Nature Communications 9 (1), 3533, 2018
Mandates: US National Institutes of Health
Developmental chromatin programs determine oncogenic competence in melanoma
A Baggiolini, SJ Callahan, E Montal, JM Weiss, T Trieu, MM Tagore, ...
Science 373 (6559), eabc1048, 2021
Mandates: Swiss National Science Foundation, US National Institutes of Health …
Publication and funding information is determined automatically by a computer program